Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal a
(Q36938662)
scientific article published on 06 May 2013
scientific article published on 06 May 2013
Language: